Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injury.
Plomgaard AM, van Oeveren W, Petersen TH, Alderliesten T, Austin T, van Bel F, Benders M, Claris O, Dempsey E, Franz A, Fumagalli M, Gluud C, Hagmann C, Hyttel-Sorensen S, Lemmers P, Pellicer A, Pichler G, Winkel P, Greisen G. Plomgaard AM, et al. Pediatr Res. 2016 Apr;79(4):528-35. doi: 10.1038/pr.2015.266. Epub 2015 Dec 17. Pediatr Res. 2016. PMID: 26679155 Free PMC article. Clinical Trial.
Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial.
Hyttel-Sorensen S, Pellicer A, Alderliesten T, Austin T, van Bel F, Benders M, Claris O, Dempsey E, Franz AR, Fumagalli M, Gluud C, Grevstad B, Hagmann C, Lemmers P, van Oeveren W, Pichler G, Plomgaard AM, Riera J, Sanchez L, Winkel P, Wolf M, Greisen G. Hyttel-Sorensen S, et al. Among authors: plomgaard am. BMJ. 2015 Jan 5;350:g7635. doi: 10.1136/bmj.g7635. BMJ. 2015. PMID: 25569128 Free PMC article. Clinical Trial.
Brain injury in the international multicenter randomized SafeBoosC phase II feasibility trial: cranial ultrasound and magnetic resonance imaging assessments.
Plomgaard AM, Hagmann C, Alderliesten T, Austin T, van Bel F, Claris O, Dempsey E, Franz A, Fumagalli M, Gluud C, Greisen G, Hyttel-Sorensen S, Lemmers P, Pellicer A, Pichler G, Benders M. Plomgaard AM, et al. Pediatr Res. 2016 Mar;79(3):466-72. doi: 10.1038/pr.2015.239. Epub 2015 Nov 16. Pediatr Res. 2016. PMID: 26571218 Free PMC article. Clinical Trial.
The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readings.
Riera J, Hyttel-Sorensen S, Bravo MC, Cabañas F, López-Ortego P, Sanchez L, Ybarra M, Dempsey E, Greisen G, Austin T, Claris O, Fumagalli M, Gluud C, Lemmers P, Pichler G, Plomgaard AM, van Bel F, Wolf M, Pellicer A. Riera J, et al. Among authors: plomgaard am. Arch Dis Child Fetal Neonatal Ed. 2016 Jul;101(4):F333-8. doi: 10.1136/archdischild-2015-308829. Epub 2015 Dec 8. Arch Dis Child Fetal Neonatal Ed. 2016. PMID: 26645538 Free PMC article. Clinical Trial.
Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial.
Plomgaard AM, Alderliesten T, Austin T, van Bel F, Benders M, Claris O, Dempsey E, Fumagalli M, Gluud C, Hagmann C, Hyttel-Sorensen S, Lemmers P, van Oeveren W, Pellicer A, Petersen TH, Pichler G, Winkel P, Greisen G. Plomgaard AM, et al. PLoS One. 2017 Mar 22;12(3):e0173440. doi: 10.1371/journal.pone.0173440. eCollection 2017. PLoS One. 2017. PMID: 28328980 Free PMC article. Clinical Trial.
No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life.
Plomgaard AM, Alderliesten T, van Bel F, Benders M, Claris O, Cordeiro M, Dempsey E, Fumagalli M, Gluud C, Hyttel-Sorensen S, Lemmers P, Pellicer A, Pichler G, Greisen G. Plomgaard AM, et al. Acta Paediatr. 2019 Feb;108(2):275-281. doi: 10.1111/apa.14463. Epub 2018 Jul 5. Acta Paediatr. 2019. PMID: 29908039 Free PMC article. Clinical Trial.
16 results